Monument Capital Management
Source: SEC Form 13F · as of Mar 2026Monument Capital Management holds 16 biotech & pharma companies tracked by BioSniper, totaling $30.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$30.4M
| Company | Shares | Value |
|---|---|---|
| MCKMcKesson Corporation | 5,609 | $4.9M |
| JNJJOHNSON & JOHNSON | 17,109 | $4.2M |
| CAHCardinal Health Inc. | 19,428 | $4.1M |
| GILDGILEAD SCIENCES, INC. | 27,946 | $3.9M |
| INCYIncyte Corp. | 28,605 | $2.7M |
| MRKMerck & Co., Inc. | 21,955 | $2.6M |
| LLYELI LILLY & Co | 2,418 | $2.2M |
| ABBVAbbVie Inc. | 6,183 | $1.3M |
| PMPhilip Morris International Inc | 6,495 | $1.1M |
| AMGNAMGEN INC | 2,666 | $938K |
| NVSNovartis AG | 5,076 | $775K |
| BMYBRISTOL MYERS SQUIBB CO | 9,125 | $553K |
| CORCencora Inc. | 1,553 | $488K |
| AZNASTRAZENECA PLC | 1,928 | $380K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 5,257 | $290K |
| NOTVInotiv, Inc. | 32,421 | $9K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.